OPKO Health Return on Tangible Equity 2010-2025 | OPK
Current and historical return on tangible equity values for OPKO Health (OPK) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| OPKO Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.04B | $0.27B | -16.99% |
| 2024-12-31 | $-0.05B | $0.22B | -30.55% |
| 2024-09-30 | $-0.13B | $0.23B | -101.33% |
| 2024-06-30 | $-0.24B | $0.21B | -247.57% |
| 2024-03-31 | $-0.25B | $0.04B | -295.60% |
| 2023-12-31 | $-0.19B | $0.05B | -167.11% |
| 2023-09-30 | $-0.21B | $0.09B | -153.05% |
| 2023-06-30 | $-0.21B | $0.16B | -124.96% |
| 2023-03-31 | $-0.29B | $0.15B | -147.16% |
| 2022-12-31 | $-0.33B | $0.14B | -155.27% |
| 2022-09-30 | $-0.32B | $0.22B | -82.02% |
| 2022-06-30 | $-0.20B | $0.28B | -40.75% |
| 2022-03-31 | $-0.12B | $0.21B | -19.96% |
| 2021-12-31 | $-0.03B | $0.84B | -4.47% |
| 2021-09-30 | $0.08B | $0.66B | 12.90% |
| 2021-06-30 | $0.07B | $0.62B | 13.14% |
| 2021-03-31 | $0.12B | $0.56B | 24.69% |
| 2020-12-31 | $0.03B | $0.52B | 7.04% |
| 2020-09-30 | $-0.11B | $0.46B | -27.23% |
| 2020-06-30 | $-0.20B | $0.42B | -50.38% |
| 2020-03-31 | $-0.29B | $0.37B | -73.71% |
| 2019-12-31 | $-0.32B | $0.41B | -74.51% |
| 2019-09-30 | $-0.28B | $0.38B | -63.63% |
| 2019-06-30 | $-0.25B | $0.43B | -53.96% |
| 2019-03-31 | $-0.19B | $0.47B | -41.61% |
| 2018-12-31 | $-0.15B | $0.48B | -33.91% |
| 2018-09-30 | $-0.30B | $0.44B | -66.63% |
| 2018-06-30 | $-0.30B | $0.45B | -61.03% |
| 2018-03-31 | $-0.31B | $0.44B | -57.04% |
| 2017-12-31 | $-0.31B | $0.44B | -50.58% |
| 2017-09-30 | $-0.13B | $0.66B | -19.23% |
| 2017-06-30 | $-0.10B | $0.66B | -16.22% |
| 2017-03-31 | $-0.07B | $0.65B | -11.74% |
| 2016-12-31 | $-0.05B | $0.62B | -8.03% |
| 2016-09-30 | $-0.01B | $0.62B | -1.52% |
| 2016-06-30 | $0.13B | $0.52B | 23.39% |
| 2016-03-31 | $0.08B | $0.63B | 13.54% |
| 2015-12-31 | $-0.03B | $0.60B | -5.66% |
| 2015-09-30 | $-0.09B | $0.55B | -16.43% |
| 2015-06-30 | $-0.26B | $0.44B | -49.46% |
| 2015-03-31 | $-0.24B | $0.53B | -42.55% |
| 2014-12-31 | $-0.17B | $0.55B | -29.95% |
| 2014-09-30 | $-0.14B | $0.60B | -23.45% |
| 2014-06-30 | $-0.15B | $0.62B | -25.67% |
| 2014-03-31 | $-0.13B | $0.53B | -27.41% |
| 2013-12-31 | $-0.12B | $0.57B | -31.81% |
| 2013-09-30 | $-0.10B | $0.57B | -44.59% |
| 2013-06-30 | $-0.05B | $0.15B | -58.68% |
| 2013-03-31 | $-0.06B | $0.16B | -104.59% |
| 2012-12-31 | $-0.03B | $0.01B | -120.39% |
| 2012-09-30 | $-0.01B | $0.01B | -36.09% |
| 2012-06-30 | $-0.01B | $0.04B | -21.89% |
| 2012-03-31 | $-0.01B | $0.04B | -9.52% |
| 2011-12-31 | $0.00B | $0.04B | -3.87% |
| 2011-09-30 | $-0.02B | $0.08B | -31.88% |
| 2011-06-30 | $-0.02B | $0.09B | -42.42% |
| 2011-03-31 | $-0.02B | $0.10B | -60.27% |
| 2010-12-31 | $-0.02B | $0.01B | -96.55% |
| 2010-09-30 | $-0.03B | $0.00B | -133.33% |
| 2010-06-30 | $-0.03B | $0.03B | -88.89% |
| 2010-03-31 | $-0.03B | $0.04B | -87.32% |
| 2009-12-31 | $-0.04B | $0.01B | -159.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.063B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.869B | 80.53 |
| Thermo Fisher Scientific (TMO) | United States | $156.785B | 18.97 |
| Edwards Lifesciences (EW) | United States | $44.517B | 29.19 |
| Alcon (ALC) | Switzerland | $43.958B | 29.71 |
| IDEXX Laboratories (IDXX) | United States | $42.376B | 48.70 |
| DexCom (DXCM) | United States | $32.486B | 50.21 |
| IQVIA Holdings (IQV) | United States | $27.529B | 15.42 |
| Mettler-Toledo (MTD) | United States | $24.694B | 29.37 |
| STERIS (STE) | Ireland | $23.846B | 26.26 |
| Waters (WAT) | United States | $20.803B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.964B | 0.00 |
| Hologic (HOLX) | United States | $14.534B | 15.79 |
| Sysmex ADR (SSMXY) | Japan | $10.991B | 31.18 |
| Penumbra (PEN) | United States | $9.813B | 77.02 |
| Masimo (MASI) | United States | $8.965B | 33.07 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.395B | 8.91 |
| TransMedics (TMDX) | United States | $4.838B | 105.18 |
| Integer Holdings (ITGR) | United States | $4.143B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.384B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.543B | 15.14 |
| Nihon Kohden (NHNKY) | Japan | $2.185B | 25.06 |
| Veracyte (VCYT) | United States | $2.090B | 29.33 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.662B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.393B | 0.00 |
| Artivion (AORT) | United States | $1.227B | 114.96 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.986B | 5.24 |
| Beta Bionics (BBNX) | United States | $0.845B | 0.00 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| IRadimed (IRMD) | United States | $0.757B | 38.43 |
| RxSight (RXST) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 8.90 |
| Mesa Laboratories (MLAB) | United States | $0.545B | 12.77 |
| Delcath Systems (DCTH) | United States | $0.545B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.528B | 0.00 |
| AxoGen (AXGN) | United States | $0.457B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.354B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.343B | 9.12 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| 908 Devices (MASS) | United States | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.231B | 14.01 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| CVRx (CVRX) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 49.70 |
| EnVVeno Medical (NVNO) | United States | $0.077B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.54 |